Overview of Checkpoint Inhibitors Mechanism of Action: Role of Immune-Related Adverse Events and Their Treatment on Progression of Underlying Cancer
暂无分享,去创建一个
E. Felip | S. Cedrés | A. Navarro | J. Frigola | A. Martínez-Martí | J. Assaf | A. Callejo | N. Pardo | Caterina Carbonell | R. Amat | D. García-Illescas | P. Iranzo | Gaspar Molina | D. Lopez | S. Cedres | J. D. Assaf